Good Manufacturing Practice Regulations for Probiotic Based Pharmaceuticals: Current Scenario and Suggestive Recommendations
Bibliographic record
Abstract
Background: Usage of probiotic based products has shown a rapid and worldwide growth due to their unlimited therapeutic benefits. Though probiotics are being exploited since ancient times but now a days major issue of concern is their emergence as drugs. In concern to their exponentially increasing market value, their quality, safety and efficacy related affairs are becoming significantly important not only for the consumers rather for manufacturers as well as regulators. As per ongoing scenario, regulatory guidelines stipulating requirements of Good Manufacturing Practice (GMP) are not yet covered properly by any of the country except canada and hence regulatory regimes seems to be highly unsatisfactory. </p> <p> Methods: GMP issues related to probiotic based products were reviewed using secondary sources i.e. electronic databases including Google Scholar, Scopus, Pubmed along with open online resources from journals, market reports, proceedings, books and web pages of relevant regulatory authorities. Later various parameters were critically analyzed for their merits and demerits and future recommendations have been suggested. </p> <p> Results: This paper has been designed to outlook the current regulatory aspects specifically in context to GMP of the probiotic based drug products and to discuss various problematic issues of concern. Above all, the prime aim of the article is to recommend suggestive consolidations to be followed for the manufacturing of the probiotic products. </p> <p> Conclusion: Stringently controlled GMP therefore will remain a most important tool to ensure prescribed standards as well as adequately adopted control measures for meeting finished probiotic products with desired and acceptable quality before their release into market. Suggested recommendations for adopting GMP in production of probiotics in this paper may act as a baseline for regulatory agencies across the globe to formulate the guidelines for the same.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.062 | 0.024 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.000 |
| Science and technology studies | 0.001 | 0.001 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.001 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; both teacher heads agree on what is shown here.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".